Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Springfield, MO
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Freehold, NJ
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Freehold, NJ
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Wyomissing, PA
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Spokane, WA
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
mi
from
Buenos Aires,
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Birmingham, AL
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Huntsville, AL
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Mesa, AZ
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Palm Desert, CA
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Riverside, CA
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Santa Maria, CA
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Santa Maria, CA
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Upland, CA
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Jupiter, FL
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Jupiter, FL
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Vero Beach, FL
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Vero Beach, FL
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Zephyrhills, FL
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Baltimore, MD
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Hickory, NC
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Middleburg Heights, OH
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Philadelphia, PA
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Orangeburg, SC
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Orangeburg, SC
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Memphis, TN
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Dallas, TX
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Mesquite, TX
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Mesquite, TX
Click here to add this to my saved trials
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated:  3/24/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Elizabeth Vale,
An Open Label Extension Study in Participants With Rheumatoid Arthritis
An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.
Status: Enrolling
Updated: 3/24/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Elizabeth Vale,
Click here to add this to my saved trials
Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis
Human Factors Study for the Evaluation of the Methotrexate Prefilled Pen (50 mg/mL) for Subcutaneous Injection in Pediatric and Adolescent Patients With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  3/26/2018
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis
Human Factors Study for the Evaluation of the Methotrexate Prefilled Pen (50 mg/mL) for Subcutaneous Injection in Pediatric and Adolescent Patients With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 3/26/2018
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Epidemiology of Osteoarthritis (OA) Pain
Epidemiology of OA Pain
Status: Enrolling
Updated:  3/27/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Epidemiology of Osteoarthritis (OA) Pain
Epidemiology of OA Pain
Status: Enrolling
Updated: 3/27/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases
Health Beliefs and Health Behavior Practices Among Minorities With Rheumatic Diseases
Status: Enrolling
Updated:  3/27/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases
Health Beliefs and Health Behavior Practices Among Minorities With Rheumatic Diseases
Status: Enrolling
Updated: 3/27/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
Status: Enrolling
Updated:  3/28/2018
Centeno-Schultz Clinic
mi
from
Broomfield, CO
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment
Status: Enrolling
Updated: 3/28/2018
Centeno-Schultz Clinic
mi
from
Broomfield, CO
Click here to add this to my saved trials
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
Assessing Catabolic Marker Levels in the Knee Synovial Fluid Microenvironment After Lavage With Platelet Poor Plasma (PPP)
Status: Enrolling
Updated:  3/28/2018
Centeno-Schultz Clinic
mi
from
Broomfield, CO
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
Assessing Catabolic Marker Levels in the Knee Synovial Fluid Microenvironment After Lavage With Platelet Poor Plasma (PPP)
Status: Enrolling
Updated: 3/28/2018
Centeno-Schultz Clinic
mi
from
Broomfield, CO
Click here to add this to my saved trials
Apremilast Therapy for Acute Gouty Arthritis
Apremilast Therapy for Acute Gouty Arthritis
Status: Enrolling
Updated:  3/29/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Apremilast Therapy for Acute Gouty Arthritis
Apremilast Therapy for Acute Gouty Arthritis
Status: Enrolling
Updated: 3/29/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Early Postoperative Compex Rehab NMES Use for Total Knee Arthroplasty Patients
A 12-Month Prospective, Post-Market Study of Early Postoperative Compex® Rehab NMES Use in Total Knee Arthroplasty Patients
Status: Enrolling
Updated:  4/3/2018
OrthoIndy
mi
from
Greenwood, IN
Early Postoperative Compex Rehab NMES Use for Total Knee Arthroplasty Patients
A 12-Month Prospective, Post-Market Study of Early Postoperative Compex® Rehab NMES Use in Total Knee Arthroplasty Patients
Status: Enrolling
Updated: 4/3/2018
OrthoIndy
mi
from
Greenwood, IN
Click here to add this to my saved trials
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
Micro-processor Controlled Knee-Ankle-Foot Orthosis (C-Brace) Versus Stance-control Knee-Ankle-Foot Orthosis (SCO): Functional Outcomes in Individuals With Lower Extremity Impairment
Status: Enrolling
Updated:  4/3/2018
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
Micro-processor Controlled Knee-Ankle-Foot Orthosis (C-Brace) Versus Stance-control Knee-Ankle-Foot Orthosis (SCO): Functional Outcomes in Individuals With Lower Extremity Impairment
Status: Enrolling
Updated: 4/3/2018
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Energy Dispersive Bracing for Conservative Treatment of Knee Osteoarthritis
Status: Enrolling
Updated:  4/3/2018
OrthoIndy
mi
from
Greenwood, IN
Energy Dispersive Bracing for Conservative Treatment of Knee Osteoarthritis
Status: Enrolling
Updated: 4/3/2018
OrthoIndy
mi
from
Greenwood, IN
Click here to add this to my saved trials
Exercise and Body Composition in Juvenile Idiopathic Arthritis
"Joint Fitness": A Double-Armed Controlled Intervention to Assess the Safety and Effectiveness of Resistance Exercise Training on Muscle, Bone, Strength, Symptoms, Quality of Life and Biological Parameters in Children and Young Adults With JIA
Status: Enrolling
Updated:  4/3/2018
Johns Hopkins University
mi
from
Baltimore, MD
Exercise and Body Composition in Juvenile Idiopathic Arthritis
"Joint Fitness": A Double-Armed Controlled Intervention to Assess the Safety and Effectiveness of Resistance Exercise Training on Muscle, Bone, Strength, Symptoms, Quality of Life and Biological Parameters in Children and Young Adults With JIA
Status: Enrolling
Updated: 4/3/2018
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Studies of Heritable Disorders of Connective Tissue
Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue
Status: Enrolling
Updated:  4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
Studies of Heritable Disorders of Connective Tissue
Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue
Status: Enrolling
Updated: 4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Strong Brain Study
A Pilot Study to Evaluate the Role of Brain Integrity on Post-hospital Sarcopenia
Status: Enrolling
Updated:  4/4/2018
Institute on Aging
mi
from
Gainesville, FL
The Strong Brain Study
A Pilot Study to Evaluate the Role of Brain Integrity on Post-hospital Sarcopenia
Status: Enrolling
Updated: 4/4/2018
Institute on Aging
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
ArthroCare, Arthritis Care Research
mi
from
Gilbert, AZ
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
ArthroCare, Arthritis Care Research
mi
from
Gilbert, AZ
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
UCLA
mi
from
Los Angeles, CA
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
Inland Rheumatology Clinical Trials Incorporated
mi
from
Upland, CA
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
Inland Rheumatology Clinical Trials Incorporated
mi
from
Upland, CA
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
Ocala Rheumatology Research Center
mi
from
Ocala, FL
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
Ocala Rheumatology Research Center
mi
from
Ocala, FL
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
JHU Arthritis Center Baltimore
mi
from
Baltimore, MD
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
JHU Arthritis Center Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
Arthritis Treatment Center
mi
from
Frederick, MD
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
Arthritis Treatment Center
mi
from
Frederick, MD
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
The Mayo Clinic
mi
from
Rochester, MN
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
Office of Ramesh C. Gupta, MD
mi
from
Fair Lawn, NJ
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
Office of Ramesh C. Gupta, MD
mi
from
Fair Lawn, NJ
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
DJL Clinical Research
mi
from
Charlotte, NC
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
DJL Clinical Research
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated:  4/5/2018
Health Research of Oklahoma
mi
from
Oklahoma City, OK
A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
A Double-blind, Randomized, Placebo-controlled, Dose-escalation, Multi-center Study a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor
Status: Enrolling
Updated: 4/5/2018
Health Research of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials